Marvin White is the President and CEO of Aptevo Therapeutics Inc., a clinical-stage biotechnology company focused on developing novel bispecific.
Marvin White is the President and CEO of Aptevo Therapeutics Inc., a clinical-stage biotechnology company focused on developing novel bispecific immunotherapies for cancer treatment. He leads the company's clinical programs and oversees the use of their proprietary platform technologies.
Full founder directory · Investor directory · Company funding database · Fundraising library